A sensitive LC-MS/MS method to quantify methylergonovine in human plasma and its application to a pharmacokinetic study.

[1]  P. Dubruel,et al.  Development and validation of a new LC-MS/MS method for the simultaneous determination of six major ergot alkaloids and their corresponding epimers: application to some food and feed commodities , 2012 .

[2]  H. Hojo,et al.  Monitoring of methylergometrine in human breast milk by solid-phase extraction and high-performance liquid chromatography with fluorimetric detection. , 2012, Die Pharmazie.

[3]  S. González,et al.  Actualización en el uso de uterotónicos , 2012 .

[4]  S. Manrique Muñoz,et al.  [Update on the use of uterotonic agents]. , 2012, Revista espanola de anestesiologia y reanimacion.

[5]  U. Lang,et al.  Haemodynamic effects of carbetocin and oxytocin given as intravenous bolus on women undergoing caesarean delivery: a randomised trial , 2011, BJOG : an international journal of obstetrics and gynaecology.

[6]  R. Jain.  Comparison of three weighting schemes in weighted regression analysis for use in a chemistry laboratory. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[7]  E. Calandre,et al.  Efficacy and tolerability of intravenous methylergonovine in migraine female patients attending the emergency department: a pilot open-label study , 2009, Head & face medicine.

[8]  Q. Cass,et al.  Pharmaceutical trace analysis in aqueous environmental matrices by liquid chromatography-ion trap tandem mass spectrometry. , 2009, Journal of chromatography. A.

[9]  L. Fauchier,et al.  Acute Myocardial Infarction Following Oral Methyl-Ergometrine Intake , 2009, Cardiovascular Toxicology.

[10]  P. Novák,et al.  Liquid chromatography-tandem mass spectrometry characterization of ergocristam degradation products. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[11]  S. Ferrara,et al.  Highly Specific Quantification of Ergotamine in Urine, Blood, and Hair Samples by Liquid Chromatography-Tandem Mass Spectrometry , 2007, Therapeutic drug monitoring.

[12]  P. Schiff.  Ergot and its alkaloids. , 2006, American journal of pharmaceutical education.

[13]  J C Reed,et al.  Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins , 2006, Cell Death and Differentiation.

[14]  J. Tabet,et al.  Quantitative determination of five ergot alkaloids in rye flour by liquid chromatography-electrospray ionisation tandem mass spectrometry. , 2006, Journal of chromatography. A.

[15]  K. Seow,et al.  Myocardial infarction and mortality caused by methylergonovine , 2005, Acta obstetricia et gynecologica Scandinavica.

[16]  K. Rentsch,et al.  Misoprostol versus methylergometrine: pharmacokinetics in human milk. , 2004, American journal of obstetrics and gynecology.

[17]  M. Murday,et al.  Determination of dihydroergotamine in human plasma by high-performance liquid chromatography with fluorescence detection. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[18]  N. Yaegashi,et al.  Acute myocardial infarction associated with postpartum ergot alkaloid administration , 1999, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[19]  B. Feldman,et al.  Postpartum myocardial infarction induced by methergine. , 1998, The American journal of emergency medicine.

[20]  G. Blaschke,et al.  Separation of ergot alkaloids and their epimers and determination in sclerotia by capillary electrophoresis. , 1998, Journal of chromatography. A.

[21]  T. Vree,et al.  Ergot alkaloids. Current status and review of clinical pharmacology and therapeutic use compared with other oxytocics in obstetrics and gynaecology. , 1998, Drugs.

[22]  L. Mueller,et al.  Methylergonovine Maleate as a Cluster Headache Prophylactic: A Study and Review , 1997, Headache.

[23]  E. Fleck,et al.  Different contractile effects of ergonovine and methylergonovine in isolated human coronary arteries , 1996 .

[24]  T. Vree,et al.  Comparison of the bioavailability and pharmacokinetics of oral methylergometrine in men and women. , 1995, International journal of clinical pharmacology and therapeutics.

[25]  G. Bittar,et al.  The Use of Methylergonovine (Methergine (r) ) in the Initial Control of Drug Induced Refractory Headache , 1993, Headache.

[26]  C. Spaulding,et al.  Coronary artery spasm triggered by oral administration of methylergometrine , 1991, The Lancet.

[27]  A. Shibata,et al.  Effect of direct intracoronary administration of methylergonovine in patients with and without variant angina. , 1991, American heart journal.

[28]  N. Molinaro,et al.  High-performance liquid chromatographic method for the determination of methysergide and methylergonovine in human plasma. , 1988, Journal of chromatography.

[29]  N. J. Giarman.  5- Hydroxytryptamine , 1958, Revue medicale de Liege.